GUANGZHOU, China, April 27, 2025 /PRNewswire/ — “It looks like we are walking straight into the future.” said British influencer Jason talking to the camera at China Import and Export Fair, also widely known as the Canton Fair.
As the world’s largest trade exhibition, the 137th Canton Fair has attracted buyers from over 200 countries and regions, with over 30,000 companies participating in. All types of cutting-edge technologies created dazzling sparks in the lens of Jason at the Service Robots Zone.
In the smart home appliances section, Jason was drawn to a refrigerator that can “think”—it provides recipes based on ingredient inventory and even enables users to check its contents remotely via smartphone. In the new energy vehicle section, autonomous electric cars and swappable-battery scooters left Jason exclaiming, “This is the future of transportation!”
The significance of the Canton Fair goes far beyond an exhibition; it provides a stage for real-time global trade transactions. Every year, buyers from over 200 countries strike deals worth billions of dollars here, forging partnerships that shape global supply chains. “This is no ordinary trade show,” Jason said in his video. “As a global commerce hub, it showcases not just business opportunities but also the immense momentum behind ‘Made in China.'”
Jason’s video has attracted enthusiastic responses on international social media platforms, with many global netizens commenting, “Jason is the most enthusiastic explorer in China to share values of truth.”
Want to experience the Canton Fair through Jason’s first-person perspective? Click on the video and join us on this journey of technology and commerce!
YouTube Link：https://www.youtube.com/watch?v=TvKvlB5qPOg
ข่าวที่เกี่ยวข้อง
- Xinhua Silk Road: Jing’an District promotes investment opportunities, global business cooperation at 2026 CIIE
- Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets
- Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity
- Ali Y. Koç: ‘The Energy Transition Has Become the Cornerstone of Competitiveness in Industry’
